Sarepta Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Sarepta Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 5.17 %.
  • Sarepta Therapeutics, Inc. annual Return On Equity for 2023 was -69.7 %, a 40.6% increase from 2022.
  • Sarepta Therapeutics, Inc. annual Return On Equity for 2022 was -117 %, a 69.3% decline from 2021.
  • Sarepta Therapeutics, Inc. annual Return On Equity for 2021 was -69.3 %, a 20.1% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 5.17 +165 Apr 1, 2024 Jun 30, 2024
Q1 2024 2.03 +200 Jan 1, 2024 Mar 31, 2024
Q4 2023 -69.7 +47.6 +40.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -106 -8.77 -9.01% Jul 1, 2023 Sep 30, 2023
Q2 2023 -160 -92 -135% Apr 1, 2023 Jun 30, 2023
Q1 2023 -198 -146 -280% Jan 1, 2023 Mar 31, 2023
Q4 2022 -117 -48 -69.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -97.4 -11 -12.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -68 +26.9 +28.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -52.1 +35.1 +40.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -69.3 -11.6 -20.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -86.4 -24.7 -40.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -94.9 -41.9 -79% Apr 1, 2021 Jun 30, 2021
Q1 2021 -87.1 -22.5 -34.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -57.7 +9.43 +14% Oct 1, 2020 Dec 31, 2020
Q3 2020 -61.6 -6.18 -11.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -53 +2.35 +4.24% Apr 1, 2020 Jun 30, 2020
Q1 2020 -64.7 -21.3 -49.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -67.1 -21.1 -46% Oct 1, 2019 Dec 31, 2019
Q3 2019 -55.4 -21.7 -64.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -55.4 -26.2 -89.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -43.4 -17.6 -68.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -46 -37.2 -420% Oct 1, 2018 Dec 31, 2018
Q3 2018 -33.7 -8.72 -34.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -29.2 +2.78 +8.69% Apr 1, 2018 Jun 30, 2018
Q1 2018 -25.8 +12.3 +32.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -8.84 +97.5 +91.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -25 +88.3 +77.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -32 +134 +80.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -38.1 +103 +73% Jan 1, 2017 Mar 31, 2017
Q4 2016 -106 +23.2 +17.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -113 -4.92 -4.54% Jul 1, 2016 Sep 30, 2016
Q2 2016 -166 -87.6 -111% Apr 1, 2016 Jun 30, 2016
Q1 2016 -141 -75.9 -116% Jan 1, 2016 Mar 31, 2016
Q4 2015 -129 -78.4 -153% Oct 1, 2015 Dec 31, 2015
Q3 2015 -108 -70.7 -187% Jul 1, 2015 Sep 30, 2015
Q2 2015 -78.7 -34.5 -78.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -65.4 -17 -35.2% Jan 1, 2015 Mar 31, 2015
Q4 2014 -51.1 +15.7 +23.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -37.7 +83.2 +68.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 -44.2 +190 +81.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -48.4 +206 +81% Jan 1, 2014 Mar 31, 2014
Q4 2013 -66.8 +245 +78.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 -121 +264 +68.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 -234 -173 -285% Apr 1, 2013 Jun 30, 2013
Q1 2013 -255 -176 -226% Jan 1, 2013 Mar 31, 2013
Q4 2012 -312 Oct 1, 2012 Dec 31, 2012
Q3 2012 -385 Jul 1, 2012 Sep 30, 2012
Q2 2012 -60.8 Apr 1, 2012 Jun 30, 2012
Q1 2012 -78.1 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.